Manuela Merli is an expert in Hepatology at Sapienza University of Rome (Italy). As of October 2026, ScienceLeadR ranks Manuela Merli in the top 1% of experts worldwide for Sarcopenia, Hepatic Insufficiency and Liver Failure. Manuela Merli has authored 538 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 1 of them ongoing. SLR score: 1,949 (community average: 125). How the SLR is computed.

LeadR Profile

Manuela Merli Sapienza University of Rome Italy
1 949 ScienceLeadR Reputation 1949
Network Map

Hepatology

Subspecialties: Gastroenterology - Public Health - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 538

Citations

Citations: 16 716 1st author: 53 Last author: 147 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.
PMID 42757700 — mortality, muscles, liver, muscle, skeletal, prognosis, sarcopenia
Liver Int20260
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
PMID 42720163 — safety, crohn disease, inflammatory bowel diseases, pharmacology, therapeutics, prospective studies
Aliment Pharmacol Ther20261
Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].
PMID 42502052 — liver diseases, acute-on-chronic liver failure, liver, liver failure
J Hepatol Top journal20260
Impact of non-selective beta-blockers on acute kidney injury outcomes in patients with decompensated cirrhosis.
PMID 42457041 — liver diseases, carvedilol, liver transplantation, mortality, acute-on-chronic liver failure, propranolol, kidney, liver, sepsis, diagnosis, therapeutics, renal replacement therapy, hemodynamics, acute kidney injury
J Hepatol Top journal20260
Pre-liver transplant assessment of patients with acute-on-chronic liver failure: An international survey.
PMID 42391791 — research design, liver transplantation, acute-on-chronic liver failure, stress, physiological, ear, angiography, liver, transplants, intensive care units, outpatients, nose, pharynx, colonoscopy, liver failure
JHEP Rep20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 9
Phase 4 4
Phase 2 1

By status:

Completed 6
Unknown 4
Recruiting 2
Terminated 2

By type:

Interventional 7
Observational 7

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 2
multicentric5to9 0
multicentricup10 5

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to investigate the long term safety tolerability and efficacy of balinatunfib in participants with Crohn s disease or ulcerative colitis
2025-522511-42-00 — colitis, safety, crohn disease, colitis, ulcerative
Phase 2Recruiting2026

LeadR Networks

Main global connection map